TFS Capital’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-38,771
| Closed | -$143K | – | 1348 |
|
|
2016
Q1 | $143K | Sell |
38,771
-335,820
| -90% | -$1.24M | 0.02% | 831 |
|
|
2015
Q4 | $3.78M | Buy |
374,591
+189,644
| +103% | +$1.92M | 0.41% | 50 |
|
|
2015
Q3 | $2.52M | Buy |
184,947
+153,996
| +498% | +$2.09M | 0.24% | 111 |
|
|
2015
Q2 | $587K | Buy |
+30,951
| New | +$587K | 0.06% | 475 |
|
|
2015
Q1 | – | Sell |
-27,750
| Closed | -$581K | – | 1262 |
|
|
2014
Q4 | $581K | Buy |
+27,750
| New | +$581K | 0.06% | 541 |
|
|
2014
Q3 | – | Sell |
-102,410
| Closed | -$3.29M | – | 1365 |
|
|
2014
Q2 | $3.29M | Buy |
102,410
+21,091
| +26% | +$677K | 0.26% | 86 |
|
|
2014
Q1 | $3.76M | Sell |
81,319
-26,096
| -24% | -$1.21M | 0.25% | 96 |
|
|
2013
Q4 | $7.62M | Buy |
+107,415
| New | +$7.62M | 0.36% | 31 |
|